Lunit helps physicians make accurate and objective diagnoses
through machine learning technology.

Latest News

The Deep Learning Market Map

The Deep Learning Market Map: 60+ Startups Working Across E-Commerce, Cybersecurity, Sales, And More

기술력에서 구글을 제친 스타트업

루닛은 이미지 인식 기술을 기반으로 인공지능이 영상자료를 분석해 병을 판별하는 스타트업이다. 현재 결핵의 경우 90% 이상의 정확성을 기록하고 있고, 좀 더 복잡하고 판독이 어려운 유방암은 81%의 정확성을 보여주고 있다.

‘닥터 인공지능’, 의사가 놓친 결핵을 찾아내다

벤처, 결핵 진단 프로그램 개발, 1만장의 폐 사진을 머신러닝하여 결핵 가능성을 퍼센트로 말하는 인공지능 앞에 의사들이 섰다

Our Vision

We founded Lunit to study, discover, and design better models between diseases and medical images to serve as a foundation for better patient care via development of our signature Data-driven Imaging Biomarker (DIB) technology.

Data-Driven Imaging Biomarker

DIB technology is an imaging biomarker derived from large-scale medical image data. Letting the machine define important diagnostic features by itself without guidance from previously established medical criteria (defined by humans) is key to our deep learning technology. By expanding beyond the status quo scope of diagnostic criteria, we envision a constructive partnership between physicians and our technology in becoming "better together" faced with challenges in accurate diagnoses of diseases.